BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,132 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $226,155 | -21.7% | 6,761 | 0.0% | 0.01% | -27.3% |
Q1 2024 | $288,965 | +8.3% | 6,761 | -2.0% | 0.01% | 0.0% |
Q4 2023 | $266,831 | -14.4% | 6,902 | -16.4% | 0.01% | -15.4% |
Q3 2023 | $311,695 | -34.2% | 8,259 | -20.5% | 0.01% | -31.6% |
Q2 2023 | $473,460 | +6.2% | 10,392 | -5.4% | 0.02% | +5.6% |
Q1 2023 | $445,714 | +90125.5% | 10,989 | +13.5% | 0.02% | -14.3% |
Q4 2022 | $494 | -99.9% | 9,684 | +41.2% | 0.02% | +23.5% |
Q3 2022 | $369,000 | +0.8% | 6,859 | +20.2% | 0.02% | +6.2% |
Q2 2022 | $366,000 | -16.4% | 5,704 | +1.0% | 0.02% | 0.0% |
Q1 2022 | $438,000 | +100.0% | 5,647 | +120.8% | 0.02% | +100.0% |
Q4 2021 | $219,000 | +6.3% | 2,557 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $206,000 | -13.8% | 2,557 | -14.0% | 0.01% | -20.0% |
Q2 2021 | $239,000 | -7.7% | 2,974 | -3.3% | 0.01% | -9.1% |
Q1 2021 | $259,000 | +15.6% | 3,074 | +10.1% | 0.01% | 0.0% |
Q4 2020 | $224,000 | 0.0% | 2,791 | 0.0% | 0.01% | -8.3% |
Q3 2020 | $224,000 | -28.2% | 2,791 | -23.0% | 0.01% | -33.3% |
Q2 2020 | $312,000 | +14.7% | 3,627 | +8.1% | 0.02% | 0.0% |
Q1 2020 | $272,000 | -3.2% | 3,356 | 0.0% | 0.02% | +20.0% |
Q4 2019 | $281,000 | -37.6% | 3,356 | -34.7% | 0.02% | -42.3% |
Q3 2019 | $450,000 | +2.0% | 5,141 | -4.5% | 0.03% | 0.0% |
Q2 2019 | $441,000 | -3.7% | 5,381 | -4.4% | 0.03% | -13.3% |
Q1 2019 | $458,000 | +25.8% | 5,631 | +1.8% | 0.03% | +25.0% |
Q4 2018 | $364,000 | -35.2% | 5,531 | -24.1% | 0.02% | -25.0% |
Q3 2018 | $562,000 | -2.8% | 7,287 | -6.9% | 0.03% | -11.1% |
Q2 2018 | $578,000 | -19.0% | 7,827 | -28.8% | 0.04% | +63.6% |
Q1 2018 | $714,000 | +63.8% | 10,990 | +62.9% | 0.02% | -12.0% |
Q4 2017 | $436,000 | +3.1% | 6,745 | 0.0% | 0.02% | -3.8% |
Q3 2017 | $423,000 | -8.4% | 6,745 | -11.5% | 0.03% | -10.3% |
Q2 2017 | $462,000 | +20.3% | 7,625 | +2.9% | 0.03% | +16.0% |
Q1 2017 | $384,000 | +11.6% | 7,411 | -4.3% | 0.02% | +8.7% |
Q4 2016 | $344,000 | -13.6% | 7,747 | -7.4% | 0.02% | -14.8% |
Q3 2016 | $398,000 | +9.3% | 8,367 | +3.8% | 0.03% | +8.0% |
Q2 2016 | $364,000 | +10.0% | 8,057 | 0.0% | 0.02% | +4.2% |
Q1 2016 | $331,000 | +2.2% | 8,057 | -5.0% | 0.02% | -7.7% |
Q4 2015 | $324,000 | +12.5% | 8,482 | -3.3% | 0.03% | +8.3% |
Q3 2015 | $288,000 | -55.6% | 8,772 | -5.4% | 0.02% | -53.8% |
Q2 2015 | $648,000 | +2.0% | 9,269 | 0.0% | 0.05% | +2.0% |
Q1 2015 | $635,000 | +1.9% | 9,269 | +9.0% | 0.05% | -1.9% |
Q4 2014 | $623,000 | -0.8% | 8,503 | -2.8% | 0.05% | -8.8% |
Q3 2014 | $628,000 | +35.6% | 8,750 | +36.7% | 0.06% | +32.6% |
Q2 2014 | $463,000 | +25.8% | 6,400 | +28.0% | 0.04% | +13.2% |
Q1 2014 | $368,000 | +21.5% | 5,000 | +14.8% | 0.04% | +15.2% |
Q4 2013 | $303,000 | +5.9% | 4,357 | +0.0% | 0.03% | -2.9% |
Q3 2013 | $286,000 | +33.6% | 4,355 | +41.2% | 0.03% | +30.8% |
Q2 2013 | $214,000 | – | 3,085 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |